These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15742578)

  • 1. Pharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.
    Outterson K
    Yale J Health Policy Law Ethics; 2005; 5(1):193-291. PubMed ID: 15742578
    [No Abstract]   [Full Text] [Related]  

  • 2. Pills, patents, and power: state creation of gray markets as a limit on patent rights.
    Ghosh S
    Fla J Int Law; 2002; 14(2):217-60. PubMed ID: 16526138
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of drug reimportation on managed care pharmacy.
    Penna P
    Manag Care Interface; 2003 Jul; 16(7):41-2. PubMed ID: 12908216
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction: pharmaceutical innovation: law & the public's health.
    Outterson K
    J Law Med Ethics; 2009; 37(2):173-5. PubMed ID: 19493064
    [No Abstract]   [Full Text] [Related]  

  • 6. Rights, patents, markets and the global AIDS pandemic.
    Gathii JT
    Fla J Int Law; 2002; 14(2):261-352. PubMed ID: 16526139
    [No Abstract]   [Full Text] [Related]  

  • 7. Trips and public health: solutions for ensuring global access to essential AIDS medication in the wake of the Paragraph 6 Waiver.
    Greenbaum JL
    J Contemp Health Law Policy; 2008; 25(1):142-65. PubMed ID: 19137750
    [No Abstract]   [Full Text] [Related]  

  • 8. Prescription drug benefits for seniors and public/private collaboration.
    Brekke M
    Beginnings; 2002; 22(3):11. PubMed ID: 12046112
    [No Abstract]   [Full Text] [Related]  

  • 9. Eliminating innovation: how price controls limit access.
    Ingram J
    J Leg Med; 2011 Jan; 32(1):115-28. PubMed ID: 21391059
    [No Abstract]   [Full Text] [Related]  

  • 10. Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?
    Gostin LO; Rai AK
    JAMA; 2020 Mar; 323(9):821-822. PubMed ID: 32125411
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient assistance programs: information is not our enemy.
    Choudhry NK; Lee JL; Agnew-Blais J; Corcoran C; Shrank WH
    Health Aff (Millwood); 2009; 28(3):843-4. PubMed ID: 19414896
    [No Abstract]   [Full Text] [Related]  

  • 12. International intellectual property, access to health care, and human rights: South Africa v. United States.
    Nagan WP
    Fla J Int Law; 2002; 14(2):155-91. PubMed ID: 16526137
    [No Abstract]   [Full Text] [Related]  

  • 13. Alternatives to the drug research and development model.
    Velásquez G
    Salud Colect; 2015 Mar; 11(1):23-34. PubMed ID: 25853828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of data on the U.S. health sector spring 2006.
    Hellander I
    Int J Health Serv; 2006; 36(4):787-802. PubMed ID: 17175846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilemmas in regulation of the market for pharmaceuticals.
    Maynard A; Bloor K
    Health Aff (Millwood); 2003; 22(3):31-41. PubMed ID: 12757269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 17. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescription drugs are the biggest bargain in health care, and all Americans should have access to them.
    Holmer AF
    Md Med; 2003; 4(2):48-9. PubMed ID: 12847830
    [No Abstract]   [Full Text] [Related]  

  • 19. Robbing tomorrow's generations.
    Holmer AF
    Am J Manag Care; 2002 Jun; 8(6):515-6. PubMed ID: 12068958
    [No Abstract]   [Full Text] [Related]  

  • 20. Principles of economics crucial to pharmacy students' understanding of the prescription drug market.
    Rattinger GB; Jain R; Ju J; Mullins CD
    Am J Pharm Educ; 2008 Jun; 72(3):61. PubMed ID: 18698403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.